Migraine treatment usually is with over-the-counter (OTC) migraine medication or prescription drugs.
Migraines, this type of headache often involves only one side of the head, but in some cases, patients may have pain bilaterally or on both sides. Migraine headache is a result of specific changes within the brain. It causes severe head pain that is often accompanied by sensitivity to light, sound, or smells.
This report aims to provide a comprehensive presentation of the global market for Migraine Headache Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Migraine Headache Drugs. This report contains market size and forecasts of Migraine Headache Drugs in global, including the following market information:
Global Migraine Headache Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Migraine Headache Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Almotriptan Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Migraine Headache Drugs include Pfizer, Novartis, Johnson & Johnson, GSK, Merck, Eli Lilly, Teva, AstraZeneca and Sun Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Migraine Headache Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Migraine Headache Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Migraine Headache Drugs Market Segment Percentages, by Type, 2022 (%)
- Almotriptan
- Eletriptan
- Sumatriptan
- Rizatriptan
- Zolmitriptan
- Naratriptan
- Frovatriptan
- Others
Global Migraine Headache Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Migraine Headache Drugs Market Segment Percentages, by Application, 2022 (%)
- Acute Migraine
- Common Migraine
- Classic Migraine
- Chronic Migraine
- Other Migraines
Global Migraine Headache Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Migraine Headache Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Migraine Headache Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Migraine Headache Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Novartis
- Johnson & Johnson
- GSK
- Merck
- Eli Lilly
- Teva
- AstraZeneca
- Sun Pharma
- Grunenthal
- Endo Pharmaceuticals
- Mylan
- Bayer
- Amneal Pharmaceuticals
- Apotex
- Ajanta Pharma
- Allergan
Outline of Major Chapters:
Chapter 1: Introduces the definition of Migraine Headache Drugs, market overview.
Chapter 2: Global Migraine Headache Drugs market size in revenue.
Chapter 3: Detailed analysis of Migraine Headache Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Migraine Headache Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Migraine Headache Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Migraine Headache Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Migraine Headache Drugs Overall Market Size
2.1 Global Migraine Headache Drugs Market Size: 2022 VS 2029
2.2 Global Migraine Headache Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Migraine Headache Drugs Players in Global Market
3.2 Top Global Migraine Headache Drugs Companies Ranked by Revenue
3.3 Global Migraine Headache Drugs Revenue by Companies
3.4 Top 3 and Top 5 Migraine Headache Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Migraine Headache Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Migraine Headache Drugs Players in Global Market
3.6.1 List of Global Tier 1 Migraine Headache Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Migraine Headache Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Migraine Headache Drugs Market Size Markets, 2022 & 2029
4.1.2 Almotriptan
4.1.3 Eletriptan
4.1.4 Sumatriptan
4.1.5 Rizatriptan
4.1.6 Zolmitriptan
4.1.7 Naratriptan
4.1.8 Frovatriptan
4.1.9 Others
4.2 By Type - Global Migraine Headache Drugs Revenue & Forecasts
4.2.1 By Type - Global Migraine Headache Drugs Revenue, 2018-2023
4.2.2 By Type - Global Migraine Headache Drugs Revenue, 2024-2029
4.2.3 By Type - Global Migraine Headache Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Migraine Headache Drugs Market Size, 2022 & 2029
5.1.2 Acute Migraine
5.1.3 Common Migraine
5.1.4 Classic Migraine
5.1.5 Chronic Migraine
5.1.6 Other Migraines
5.2 By Application - Global Migraine Headache Drugs Revenue & Forecasts
5.2.1 By Application - Global Migraine Headache Drugs Revenue, 2018-2023
5.2.2 By Application - Global Migraine Headache Drugs Revenue, 2024-2029
5.2.3 By Application - Global Migraine Headache Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Migraine Headache Drugs Market Size, 2022 & 2029
6.2 By Region - Global Migraine Headache Drugs Revenue & Forecasts
6.2.1 By Region - Global Migraine Headache Drugs Revenue, 2018-2023
6.2.2 By Region - Global Migraine Headache Drugs Revenue, 2024-2029
6.2.3 By Region - Global Migraine Headache Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Migraine Headache Drugs Revenue, 2018-2029
6.3.2 US Migraine Headache Drugs Market Size, 2018-2029
6.3.3 Canada Migraine Headache Drugs Market Size, 2018-2029
6.3.4 Mexico Migraine Headache Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Migraine Headache Drugs Revenue, 2018-2029
6.4.2 Germany Migraine Headache Drugs Market Size, 2018-2029
6.4.3 France Migraine Headache Drugs Market Size, 2018-2029
6.4.4 U.K. Migraine Headache Drugs Market Size, 2018-2029
6.4.5 Italy Migraine Headache Drugs Market Size, 2018-2029
6.4.6 Russia Migraine Headache Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Migraine Headache Drugs Market Size, 2018-2029
6.4.8 Benelux Migraine Headache Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Migraine Headache Drugs Revenue, 2018-2029
6.5.2 China Migraine Headache Drugs Market Size, 2018-2029
6.5.3 Japan Migraine Headache Drugs Market Size, 2018-2029
6.5.4 South Korea Migraine Headache Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Migraine Headache Drugs Market Size, 2018-2029
6.5.6 India Migraine Headache Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Migraine Headache Drugs Revenue, 2018-2029
6.6.2 Brazil Migraine Headache Drugs Market Size, 2018-2029
6.6.3 Argentina Migraine Headache Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Migraine Headache Drugs Revenue, 2018-2029
6.7.2 Turkey Migraine Headache Drugs Market Size, 2018-2029
6.7.3 Israel Migraine Headache Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Migraine Headache Drugs Market Size, 2018-2029
6.7.5 UAE Migraine Headache Drugs Market Size, 2018-2029
7 Migraine Headache Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Migraine Headache Drugs Major Product Offerings
7.1.4 Pfizer Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Migraine Headache Drugs Major Product Offerings
7.2.4 Novartis Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Migraine Headache Drugs Major Product Offerings
7.3.4 Johnson & Johnson Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 GSK
7.4.1 GSK Company Summary
7.4.2 GSK Business Overview
7.4.3 GSK Migraine Headache Drugs Major Product Offerings
7.4.4 GSK Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.4.5 GSK Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Migraine Headache Drugs Major Product Offerings
7.5.4 Merck Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.5.5 Merck Key News & Latest Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Company Summary
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Migraine Headache Drugs Major Product Offerings
7.6.4 Eli Lilly Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.6.5 Eli Lilly Key News & Latest Developments
7.7 Teva
7.7.1 Teva Company Summary
7.7.2 Teva Business Overview
7.7.3 Teva Migraine Headache Drugs Major Product Offerings
7.7.4 Teva Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.7.5 Teva Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Migraine Headache Drugs Major Product Offerings
7.8.4 AstraZeneca Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Sun Pharma
7.9.1 Sun Pharma Company Summary
7.9.2 Sun Pharma Business Overview
7.9.3 Sun Pharma Migraine Headache Drugs Major Product Offerings
7.9.4 Sun Pharma Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.9.5 Sun Pharma Key News & Latest Developments
7.10 Grunenthal
7.10.1 Grunenthal Company Summary
7.10.2 Grunenthal Business Overview
7.10.3 Grunenthal Migraine Headache Drugs Major Product Offerings
7.10.4 Grunenthal Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.10.5 Grunenthal Key News & Latest Developments
7.11 Endo Pharmaceuticals
7.11.1 Endo Pharmaceuticals Company Summary
7.11.2 Endo Pharmaceuticals Business Overview
7.11.3 Endo Pharmaceuticals Migraine Headache Drugs Major Product Offerings
7.11.4 Endo Pharmaceuticals Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.11.5 Endo Pharmaceuticals Key News & Latest Developments
7.12 Mylan
7.12.1 Mylan Company Summary
7.12.2 Mylan Business Overview
7.12.3 Mylan Migraine Headache Drugs Major Product Offerings
7.12.4 Mylan Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.12.5 Mylan Key News & Latest Developments
7.13 Bayer
7.13.1 Bayer Company Summary
7.13.2 Bayer Business Overview
7.13.3 Bayer Migraine Headache Drugs Major Product Offerings
7.13.4 Bayer Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.13.5 Bayer Key News & Latest Developments
7.14 Amneal Pharmaceuticals
7.14.1 Amneal Pharmaceuticals Company Summary
7.14.2 Amneal Pharmaceuticals Business Overview
7.14.3 Amneal Pharmaceuticals Migraine Headache Drugs Major Product Offerings
7.14.4 Amneal Pharmaceuticals Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.14.5 Amneal Pharmaceuticals Key News & Latest Developments
7.15 Apotex
7.15.1 Apotex Company Summary
7.15.2 Apotex Business Overview
7.15.3 Apotex Migraine Headache Drugs Major Product Offerings
7.15.4 Apotex Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.15.5 Apotex Key News & Latest Developments
7.16 Ajanta Pharma
7.16.1 Ajanta Pharma Company Summary
7.16.2 Ajanta Pharma Business Overview
7.16.3 Ajanta Pharma Migraine Headache Drugs Major Product Offerings
7.16.4 Ajanta Pharma Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.16.5 Ajanta Pharma Key News & Latest Developments
7.17 Allergan
7.17.1 Allergan Company Summary
7.17.2 Allergan Business Overview
7.17.3 Allergan Migraine Headache Drugs Major Product Offerings
7.17.4 Allergan Migraine Headache Drugs Revenue in Global Market (2018-2023)
7.17.5 Allergan Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Migraine Headache Drugs Market Opportunities & Trends in Global Market
Table 2. Migraine Headache Drugs Market Drivers in Global Market
Table 3. Migraine Headache Drugs Market Restraints in Global Market
Table 4. Key Players of Migraine Headache Drugs in Global Market
Table 5. Top Migraine Headache Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Migraine Headache Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Migraine Headache Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Migraine Headache Drugs Product Type
Table 9. List of Global Tier 1 Migraine Headache Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Migraine Headache Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Migraine Headache Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Migraine Headache Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Migraine Headache Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Migraine Headache Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Migraine Headache Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Migraine Headache Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Migraine Headache Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Migraine Headache Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Migraine Headache Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Migraine Headache Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Migraine Headache Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Migraine Headache Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Migraine Headache Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Migraine Headache Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Migraine Headache Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Migraine Headache Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Migraine Headache Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Migraine Headache Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Migraine Headache Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Migraine Headache Drugs Product Offerings
Table 32. Pfizer Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Migraine Headache Drugs Product Offerings
Table 36. Novartis Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Migraine Headache Drugs Product Offerings
Table 40. Johnson & Johnson Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. GSK Company Summary
Table 43. GSK Migraine Headache Drugs Product Offerings
Table 44. GSK Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. GSK Key News & Latest Developments
Table 46. Merck Company Summary
Table 47. Merck Migraine Headache Drugs Product Offerings
Table 48. Merck Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. Eli Lilly Company Summary
Table 51. Eli Lilly Migraine Headache Drugs Product Offerings
Table 52. Eli Lilly Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Eli Lilly Key News & Latest Developments
Table 54. Teva Company Summary
Table 55. Teva Migraine Headache Drugs Product Offerings
Table 56. Teva Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Teva Key News & Latest Developments
Table 58. AstraZeneca Company Summary
Table 59. AstraZeneca Migraine Headache Drugs Product Offerings
Table 60. AstraZeneca Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. AstraZeneca Key News & Latest Developments
Table 62. Sun Pharma Company Summary
Table 63. Sun Pharma Migraine Headache Drugs Product Offerings
Table 64. Sun Pharma Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Sun Pharma Key News & Latest Developments
Table 66. Grunenthal Company Summary
Table 67. Grunenthal Migraine Headache Drugs Product Offerings
Table 68. Grunenthal Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Grunenthal Key News & Latest Developments
Table 70. Endo Pharmaceuticals Company Summary
Table 71. Endo Pharmaceuticals Migraine Headache Drugs Product Offerings
Table 72. Endo Pharmaceuticals Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Endo Pharmaceuticals Key News & Latest Developments
Table 74. Mylan Company Summary
Table 75. Mylan Migraine Headache Drugs Product Offerings
Table 76. Mylan Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Mylan Key News & Latest Developments
Table 78. Bayer Company Summary
Table 79. Bayer Migraine Headache Drugs Product Offerings
Table 80. Bayer Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Bayer Key News & Latest Developments
Table 82. Amneal Pharmaceuticals Company Summary
Table 83. Amneal Pharmaceuticals Migraine Headache Drugs Product Offerings
Table 84. Amneal Pharmaceuticals Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Amneal Pharmaceuticals Key News & Latest Developments
Table 86. Apotex Company Summary
Table 87. Apotex Migraine Headache Drugs Product Offerings
Table 88. Apotex Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Apotex Key News & Latest Developments
Table 90. Ajanta Pharma Company Summary
Table 91. Ajanta Pharma Migraine Headache Drugs Product Offerings
Table 92. Ajanta Pharma Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 93. Ajanta Pharma Key News & Latest Developments
Table 94. Allergan Company Summary
Table 95. Allergan Migraine Headache Drugs Product Offerings
Table 96. Allergan Migraine Headache Drugs Revenue (US$, Mn) & (2018-2023)
Table 97. Allergan Key News & Latest Developments
List of Figures
Figure 1. Migraine Headache Drugs Segment by Type in 2022
Figure 2. Migraine Headache Drugs Segment by Application in 2022
Figure 3. Global Migraine Headache Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Migraine Headache Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Migraine Headache Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Migraine Headache Drugs Revenue in 2022
Figure 8. By Type - Global Migraine Headache Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Migraine Headache Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Migraine Headache Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Migraine Headache Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Migraine Headache Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Migraine Headache Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Migraine Headache Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Migraine Headache Drugs Revenue Market Share, 2018-2029
Figure 16. US Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Migraine Headache Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Migraine Headache Drugs Revenue Market Share, 2018-2029
Figure 28. China Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Migraine Headache Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Migraine Headache Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Migraine Headache Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GSK Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Merck Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Eli Lilly Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Teva Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. AstraZeneca Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sun Pharma Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Grunenthal Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Endo Pharmaceuticals Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Mylan Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Bayer Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Amneal Pharmaceuticals Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Apotex Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Ajanta Pharma Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Allergan Migraine Headache Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
